Compare toxoid vaccines to conjugate vaccines, including examples and rationale.

• A. Toxoid vaccines use inactivated toxins (tetanus); conjugate vaccines link polysaccharide antigens to a protein carrier to improve T cell help (Haemophilus influenzae type b, pneumococcal).
• B. Toxoid vaccines use live bacteria; conjugate vaccines use kill viruses.
• C. Toxoid vaccines rely on protein carriers; conjugate vaccines rely on inactivated toxins.
• D. Toxoid vaccines induce mucosal immunity; conjugate vaccines do not.

Answer: (A)

Two main vaccine approaches differ in what the immune system is trained to recognize and how that recognition is boosted.

Toxoid vaccines use inactivated bacterial toxins as the antigen. By inactivating the toxin (for example, tetanus toxin) you train the immune system to produce antibodies that neutralize the toxin itself. Protection targets the toxin’s action rather than the bacteria, and these vaccines generally require boosters to maintain antibody levels. They are classic examples where the immune response is directed against a toxin protein produced by the organism.

Conjugate vaccines address the weak immunogenicity of polysaccharide capsules found on many bacteria. Polysaccharides alone elicit a limited, mostly T-independent antibody response, especially in young children. By attaching (conjugating) the polysaccharide to a protein carrier, the immune system provides T cell help to B cells, leading to a stronger, class-switched, and memory-oriented response. This approach is used for Haemophilus influenzae type b and Streptococcus pneumoniae vaccines, where the protein carrier enables robust immunity against the capsule polysaccharide.

So the correct statement reflects that toxoid vaccines use inactivated toxins to prevent toxin-mediated disease, while conjugate vaccines couple polysaccharide antigens to a protein carrier to recruit T cell help and produce a more durable, vaccine-induced memory response, with Hib and pneumococcal conjugate vaccines as examples.